All news

At $547.86 apiece, a director sold 271 Vertex Pharmaceuticals (VRTX) shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Vertex Pharmaceuticals Inc. (VRTX) director Sangeeta N. Bhatia sold 271 shares of common stock at $547.86 per share on November 16, 2026. This transaction was executed under a Rule 10b5-1 trading plan established on August 13, 2026. Following the sale, Dr. Bhatia directly holds 4,653 shares of the company.

Read original source

VRTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.